|106.39||+2.14||+2.05%||Vol 5.01M||1Y Perf 22.45%|
|Aug 12th, 2022 16:00 DELAYED|
|- -||0.05 0.05%|
|Target Price||116.80||Analyst Rating||Moderate Buy 1.63|
|Potential %||9.78||Finscreener Ranking||★ 41.16|
|Insiders Trans % 3/6/12 mo.||-100/-89/-79||Value Ranking||★ 41.63|
|Insiders Value % 3/6/12 mo.||-100/-99/-98||Growth Ranking||★+ 42.69|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-99/-98||Income Ranking||★ 31.71|
|Price Range Ratio 52W %||83.51||Earnings Rating||Neutral|
|Market Cap||139.67B||Earnings Date||3rd Aug 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||2.16|
|EPS Growth Next 5 Years %||7.60|
|Avg. Weekly Volume||4.22M|
|Avg. Monthly Volume||4.97M|
|Avg. Quarterly Volume||4.79M|
CVS Health Corporation (NYSE: CVS) stock closed at 106.39 per share at the end of the most recent trading day (a 2.05% change compared to the prior day closing price) with a volume of 5.01M shares and market capitalization of 139.67B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 300000 people. CVS Health Corporation CEO is Karen S. Lynch.
The one-year performance of CVS Health Corporation stock is 22.45%, while year-to-date (YTD) performance is 3.13%. CVS stock has a five-year performance of 33.98%. Its 52-week range is between 81.78 and 111.25, which gives CVS stock a 52-week price range ratio of 83.51%
CVS Health Corporation currently has a PE ratio of 17.00, a price-to-book (PB) ratio of 1.82, a price-to-sale (PS) ratio of 0.44, a price to cashflow ratio of 7.50, a PEG ratio of 2.32, a ROA of 3.76%, a ROC of 6.61% and a ROE of 11.67%. The company’s profit margin is 2.68%, its EBITDA margin is 5.70%, and its revenue ttm is $307.86 Billion , which makes it $234.50 revenue per share.
Of the last four earnings reports from CVS Health Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.16 for the next earnings report. CVS Health Corporation’s next earnings report date is -.
The consensus rating of Wall Street analysts for CVS Health Corporation is Moderate Buy (1.63), with a target price of $116.8, which is +9.78% compared to the current price. The earnings rating for CVS Health Corporation stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
CVS Health Corporation has a dividend yield of 2.11% with a dividend per share of $2.20 and a payout ratio of 35.00%.
CVS Health Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 8.65, ATR14 : 2.14, CCI20 : 131.98, Chaikin Money Flow : 0.11, MACD : 2.83, Money Flow Index : 82.31, ROC : 10.97, RSI : 80.29, STOCH (14,3) : 96.22, STOCH RSI : 1.00, UO : 52.14, Williams %R : -3.78), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of CVS Health Corporation in the last 12-months were: Alan M. Lotvin (Option Excercise at a value of $10 432 875), Alan M. Lotvin (Sold 164 826 shares of value $16 469 932 ), Daniel P. Finke (Option Excercise at a value of $2 960 553), Daniel P. Finke (Sold 70 846 shares of value $7 091 795 ), Edward J. Ludwig (Buy at a value of $105 904), James D. Clark (Option Excercise at a value of $619 593), James D. Clark (Sold 6 059 shares of value $660 431 ), Jonathan C. Roberts (Option Excercise at a value of $12 003 368), Jonathan C. Roberts (Sold 177 352 shares of value $17 704 465 ), Prem S. Shah (Option Excercise at a value of $1 716 473), Prem S. Shah (Sold 26 924 shares of value $2 833 046 ), Thomas M. Moriarty (Option Excercise at a value of $13 752 572), Thomas M. Moriarty (Sold 190 015 shares of value $18 565 035 ), Troyen A. Brennan (Option Excercise at a value of $10 923 493), Troyen A. Brennan (Sold 161 478 shares of value $15 318 371 )
Fri, 05 Aug 2022 12:45 GMT CVS Health (CVS) Receives a Buy from Jefferies- TipRanks. All rights reserved.
Mon, 04 Jul 2022 22:17 GMT CVS Health Stock: A Recession-Proof Cash Cow- TipRanks. All rights reserved.
Fri, 06 May 2022 03:55 GMT CVS Health (CVS) Receives a Buy from Mizuho Securities- TipRanks. All rights reserved.
Fri, 06 May 2022 03:50 GMT CVS Health (CVS) Receives a Buy from Evercore ISI- TipRanks. All rights reserved.
Fri, 06 May 2022 01:51 GMT CVS Health (CVS) Gets a Buy Rating from RBC Capital- TipRanks. All rights reserved.
Tue, 03 May 2022 09:13 GMT CVS Health Reports Earnings Tomorrow What Can We Expect- TipRanks. All rights reserved.
Mon, 25 Apr 2022 13:15 GMT CVS Health (CVS) Gets a Hold Rating from Deutsche Bank- TipRanks. All rights reserved.
Wed, 13 Apr 2022 09:40 GMT CVS Health (CVS) Gets a Buy Rating from Mizuho Securities- TipRanks. All rights reserved.
Mon, 11 Apr 2022 17:34 GMT CVS Health: A Healthy Stock with Some Risks- TipRanks. All rights reserved.
Thu, 07 Apr 2022 16:36 GMT CVS Health (CVS) Receives a Buy from Tigress Financial- TipRanks. All rights reserved.
Fri, 18 Mar 2022 12:15 GMT Evercore ISI Believes CVS Health (CVS) Still Has Room to Grow- TipRanks. All rights reserved.
Tue, 15 Feb 2022 18:02 GMT CVS Stock: Outlook Remains Positive- TipRanks. All rights reserved.
Fri, 11 Feb 2022 12:14 GMT J.P. Morgan Believes CVS Health (CVS) Still Has Room to Grow- TipRanks. All rights reserved.
Fri, 11 Feb 2022 10:03 GMT CVS Health Updates 2 Key Risk Factors- TipRanks. All rights reserved.
Sun, 23 Jan 2022 16:49 GMT Jefferies Believes CVS Health (CVS) Still Has Room to Grow- TipRanks. All rights reserved.
Sat, 22 Jan 2022 09:03 GMT Analysts Top Consumer Goods Picks: CVS Health (CVS)- TipRanks. All rights reserved.
Wed, 19 Jan 2022 12:36 GMT Mizuho Securities Believes CVS Health (CVS) Wont Stop Here- TipRanks. All rights reserved.
Mon, 17 Jan 2022 15:11 GMT CVS Stock: Could Outperform in 2022- TipRanks. All rights reserved.
Mon, 17 Jan 2022 06:08 GMT RBC Capital Believes CVS Health (CVS) Wont Stop Here- TipRanks. All rights reserved.
Sun, 16 Jan 2022 12:02 GMT CVS Health Corp.: Healthy Growth, but Worth the Price- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.